FDA Signals Greater Scrutiny of Foreign Clinical Data FDA doubles down on the inspectability and integrity of foreign clinical data On September 2, 2026, The U.S. Food and Drug Administration published an article with an unequivocal title: “Good Clinical Practices Are Not Optional.” The article was written by senior leaders from four FDA centers: the […]